Journal article · 2026 · Open access

T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody

Carlos Luri‐Rey, Inmaculada Rodríguez, Saioa Arrieta-Aranzueque, David Ruiz Guillamón, Enric Vercher, Nekane Soria, Paula Molero-Glez, Raquel Cuesta, Gabriel Gomis, Arantza Azpilikueta, Elixabet Bolaños, Almudena Manzanal and 15 more

Immunity, 59(11), 3081–3098.e14 · Published 28 October 2026 · DOI 10.1016/j.immuni.2026.10.003

Open PDFView at the publisherCite this paper

In brief

“T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody” is a 2026 journal article by Carlos Luri‐Rey and 26 co-authors, published in Immunity. OpenAlex counts 1 citations as of 16 November 2026, which puts it in the top 9% of works published in 2026 by citations. It is open access: the full text is free to read at Immunity.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.90
References
80
Authors
27

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Luri‐Rey, C., Rodríguez, I., Arrieta-Aranzueque, S., Guillamón, D. R., Vercher, E., Soria, N., Molero-Glez, P., Cuesta, R., Gomis, G., Azpilikueta, A., Bolaños, E., Manzanal, A., Garasa, S., Kaisho, T., Alexandru, R., Domínguez, P. P., Calvo, A., Expósito, F., Heras‐Murillo, I., . . . Melero, I. (2026). T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody. Immunity, 59(11), 3081–3098.e14. https://doi.org/10.1016/j.immuni.2026.10.003

MLA 9

Luri‐Rey, Carlos, et al. “T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody.” Immunity, vol. 59, no. 11, 2026, pp. 3081–3098.e14. https://doi.org/10.1016/j.immuni.2026.10.003.

Chicago

Luri‐Rey, Carlos, Inmaculada Rodríguez, Saioa Arrieta-Aranzueque, David Ruiz Guillamón, Enric Vercher, Nekane Soria, Paula Molero-Glez, et al. 2026. “T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody.” Immunity 59 (11): 3081–3098.e14. https://doi.org/10.1016/j.immuni.2026.10.003.

Harvard

Luri‐Rey, C. et al. (2026) ‘T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody’, Immunity, 59(11), pp. 3081–3098.e14. doi:10.1016/j.immuni.2026.10.003.

IEEE

C. Luri‐Rey et al., “T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody,” Immunity, vol. 59, no. 11, pp. 3081–3098.e14, 2026, doi: 10.1016/j.immuni.2026.10.003.

BibTeX

@article{lurirey2026cell,
  title     = {{T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody}},
  author    = {Luri‐Rey, Carlos and Rodríguez, Inmaculada and Arrieta-Aranzueque, Saioa and Guillamón, David Ruiz and Vercher, Enric and Soria, Nekane and Molero-Glez, Paula and Cuesta, Raquel and Gomis, Gabriel and Azpilikueta, Arantza and Bolaños, Elixabet and Manzanal, Almudena and Garasa, Saray and Kaisho, Tsuneyasu and Alexandru, Raluca and Domínguez, Paulo Pérez and Calvo, Alfonso and Expósito, Francisco and Heras‐Murillo, Ignacio and Sancho, David and Capello, Michela and Pencheva, Nora and Berraondo, Pedro and de Andrea, Carlos and Jure‐Kunkel, Maria and Teijeira, Álvaro and Melero, Ignacio},
  journal   = {Immunity},
  year      = {2026},
  volume    = {59},
  number    = {11},
  pages     = {3081--3098.e14},
  doi       = {10.1016/j.immuni.2026.10.003},
  url       = {https://doi.org/10.1016/j.immuni.2026.10.003}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses

  • cDC1
  • cross-presentation
  • 4-1BB costimulation
  • IL-12
  • CD40 ligand
  • Batf3
  • Flt3L
  • CD8+ T cell proliferation

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Luri‐Rey, C., Rodríguez, I., Arrieta-Aranzueque, S., Guillamón, D. R., Vercher, E., Soria, N., Molero-Glez, P., Cuesta, R., Gomis, G., Azpilikueta, A., Bolaños, E., Manzanal, A., Garasa, S., Kaisho, T., Alexandru, R., Domínguez, P. P., Calvo, A., Expósito, F., Heras‐Murillo, I., . . . Melero, I. (2026). T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody. Immunity, 59(11), 3081–3098.e14. https://doi.org/10.1016/j.immuni.2026.10.003

How many times has this paper been cited?

1 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Immunity: sign in and open the PDF from this page.

Who wrote this paper?

Carlos Luri‐Rey, Inmaculada Rodríguez, Saioa Arrieta-Aranzueque, David Ruiz Guillamón, Enric Vercher, Nekane Soria, Paula Molero-Glez, Raquel Cuesta, Gabriel Gomis, Arantza Azpilikueta, Elixabet Bolaños, Almudena Manzanal and 15 more.

What is the DOI of this paper?

10.1016/j.immuni.2026.10.003, permanently at https://doi.org/10.1016/j.immuni.2026.10.003. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.